Research Article
Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre Registry
Table 3
ECMO characteristics: PCI with ECMO support (n = 14).
| | ECMO cannulation, % (n) | | Femoral artery | 92.9 (13/14) | | Femoral antegrade cannula necessary | 7.7 (1/13) | | Subclavian artery | 7.1 (1/14) |
| | Arterial cannula size, Fr (IQR) | 17 (17–19) | | 17 French, % (n) | 66.7 (8/12) | | 19 French % (n) | 16.7 (2/12) | | 21 French % (n) | 16.7 (2/12) |
| | Anaesthesia, % (n) | | Local anesthesia with preprocedural medical sedation | 57.1 (8/14) | | Procedural sedation and analgesia | 14.3 (2/14) | | General anesthesia | 28.6 (4/14) |
| | Duration of ECMO, min (±SD) | 151 (±23) | | Prolonged ECMO support, % (n) | 7.1 (1/14) | | ECMO flow, l/min (±SD) | 2.5 (±0.2) |
| | Closure technique, % (n) | | Collagen plug-based | 23.1 (3/13) | | Suture-based closure device | 69.2 (9/13) | | Surgical | 7.7 (1/13) |
| | ECMO-related complications, % (n) | | Vascular access site or access-related | 7.1 (1/14) | | Major vascular complication | 0 (0/1) | | Minor vascular complication | 100 (1/1) |
|
|
ECMO, extracorporeal membrane oxygenation; Fr, French; N, number of treated patients; PCI, percutaneous coronary intervention; SD, standard deviation.
|
